News

String Metaverse Limited, formerly known as Bio Green Papers Limited, held an extra-ordinary general meeting on Thursday, October 15, 2026, where members approved a special resolution to issue up to 8,320,338 fully paid-up equity shares on a preferential basis for approximately Rs 73.63 crore, at an issue price of Rs 8.85 per share, including a securities premium of Rs 7.85 per share, to identified proposed allottees.

String Metaverse Limited, formerly known as Bio Green Papers Limited, will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter ended September 30, 2026, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.

String Metaverse Limited, formerly known as Bio Green Papers Limited, will close its trading window for designated persons, their immediate relatives, and other covered individuals starting Tuesday, September 15, 2026, in connection with a board meeting scheduled for Thursday, September 17, 2026, to consider and approve raising of funds by way of preferential issue/private placement of equity shares and/or other eligible securities, including convertible securities.

String Metaverse Limited, formerly known as Bio Green Papers Limited, will hold a board meeting on Thursday, September 17, 2026, to consider and approve a fundraising through the issuance of equity shares and/or other eligible securities, including convertible securities, by way of preferential issue and/or private placement, subject to regulatory approvals and shareholder approval where required.

String Metaverse Limited, formerly known as Bio Green Papers Limited, reported no deviation or variation in the utilization of proceeds from its rights issue for the quarter ended June 30, 2026, according to a filing with the BSE Limited. The company, which raised Rs 4925.15 lakh through a rights issue on May 5, 2025, noted that an amount of Rs 300.10 lakh was reallocated from issue-related expenses to general corporate purposes, remaining within the permissible limit outlined in the Letter of Offer.